Catalyst Biosciences Long Term Debt Current 2011-2026 | CBIO

Annual Long Term Debt Current Catalyst Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
636 K	713 K	210 K	492 K	1.98 M	663 K	483 K	-	-	-	-	-	853 K	851 K	1.24 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.98 M	210 K	812 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
BioNTech SE BNTX	45 M	$ 91.28	0.11 %	$ 27.2 B	Germany
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	554 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	193 K	-	-45.71 %	$ 1.2 M	Canada
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	317 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	45.5 M	$ 330.34	3.6 %	$ 43.3 B	USA
Alpine Immune Sciences ALPN	756 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	316 K	-	4.14 %	$ 49.1 M	USA
Evogene Ltd. EVGN	589 K	$ 0.79	1.22 %	$ 27.9 M	Israel
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
argenx SE ARGX	10.8 M	$ 748.25	0.25 %	$ 25 B	Niderland
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	433 K	$ 0.89	-4.33 %	$ 4.85 M	China
Applied Therapeutics APLT	429 K	-	-	$ 8.42 M	USA
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
AbbVie ABBV	194 M	$ 206.69	-1.01 %	$ 366 B	USA
Aquestive Therapeutics AQST	631 K	$ 4.09	-0.97 %	$ 437 M	USA
Aravive ARAV	2.2 M	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	5.82 M	$ 3.39	-3.69 %	$ 1.01 B	Canada
Arcturus Therapeutics Holdings ARCT	4.21 M	$ 8.22	2.37 %	$ 225 M	Israel
Ardelyx ARDX	1.48 M	$ 5.97	0.51 %	$ 1.44 B	USA
Genmab A/S GMAB	26 M	$ 27.75	0.91 %	$ 17.6 B	Danmark
Cerevel Therapeutics Holdings CERE	3.4 M	-	-	$ 7.29 B	USA
Grifols, S.A. GRFS	117 M	$ 8.23	-0.12 %	$ 6.83 B	Spain
Akebia Therapeutics AKBA	3.55 M	$ 1.32	-4.35 %	$ 339 M	USA